Futura Medical plc (AIM:FUM)
London · Delayed Price · Currency is GBP · Price in GBX 0.2780
0.00 (0.00%)
Sep 4, 2026, 4:46 PM GMT
Futura Medical Market Cap
Futura Medical has a market cap or net worth of 1.62 million as of September 4, 2026. Its market cap has decreased by -94.34% in one year.
Market Cap
1.62M
Enterprise Value
371.93K
Revenue
2.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
ChartMarket Cap Chart
Since July 22, 2003, Futura Medical's market cap has decreased from 29.74M to 1.62M, a decrease of -94.57%. That is a compound annual growth rate of -11.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.62M | -75.07% |
| Dec 31, 2025 | 6.48M | -93.26% |
| Dec 31, 2024 | 96.12M | 25.06% |
| Dec 29, 2023 | 76.86M | -47.89% |
| Dec 30, 2022 | 147.48M | 30.69% |
| Dec 31, 2021 | 112.85M | 201.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solvonis Therapeutics | 8.17M |
| Cizzle Biotechnology Holdings | 6.37M |
| CRISM Therapeutics | 6.10M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.20M |
| Oxford BioDynamics | 4.93M |
| Nuformix | 4.31M |
| Theracryf | 3.98M |